Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Leukemia 9 Leukemia, Myeloid, Acute 5 Congenital Abnormalities 5 Wilms Tumor 3 Uterine Cervical Neoplasms 3 Lung Neoplasms 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Megakaryoblastic, Acute 3 Leukemia, Erythroblastic, Acute 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Squamous Intraepithelial Lesions 2 Sarcoma 2 Ovarian Neoplasms 2 Kidney Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Neoplasms 2 Testicular Neoplasms 1 Testicular Germ Cell Tumor 1 Small Cell Lung Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Melanoma 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 58 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Drug Therapy 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4 Palliative Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × DNA Methylation × Clear all

NCT05504772 2024-07-17

ZERO2

Australian & New Zealand Children's Haematology/Oncology Group

Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡